S2Medical wins procurement for wound healing items in the United Arab Emirates worth approximately SEK 3.4 million

S2Medical AB (publ) (the "Company") has, via the Company's local partner in the United Arab Emirates, won a procurement for wound healing items within Mubadala Health LLC. The value of the procurement is estimated at approximately SEK 1.7 million per year for at least 2 years, a total of approximately SEK 3.4 million. Mubadala Health has announced that they intend to call off the procurement quarterly with orders corresponding to approximately SEK 400,000 - 500,000.

Mubadala Health is part of the Mubadala Investment Company and is one of the UAE's largest healthcare providers. Mubadala Health owns, among others, Cleveland Clinic Abu Dhabi, Healthpoint, Imperial Collage London Diabetes Centre, Amana Healthcare and several other hospital chains in the country.

"Mubadala Healthcare represents healthcare providers who deliver world-class healthcare. Our customer offering fits perfectly with their approach and we are proud to now deliver wound healing products that will improve the care of patients suffering from various types of wounds. We look forward to becoming a long-term supplier and will share the knowledge that exists within the Company to not only deliver a product, but a complete solution for all types of wounds," says the Company's COO Mårten Skog.

This disclosure contains information that S2Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 21-04-2023 15:37 CET.

Contact Details
Petter Sivlér – CEO, S2Medical AB (publ)
Telephone: +46 (0)8-70 000 50
E-mail: petter.sivler@s2m.se

Certified Adviser
Vator Securities AB
Telephone +46 (0)8-580 065 99
Website: www.vatorsec.se 
E-mail: ca@vatorsec.se

About S2Medical 

S2Medical AB (publ) is a medical technology company that develops and sells innovative wound healing products for the entire wound healing process, with a focus on burns and chronic wounds. The company has developed eiratex®, a new cellulose-based material for healing severe burns and chronic wounds. The material heals wounds effectively and thereby reduces both suffering for patients and costs for health care.

Share's ticker: S2M

Share's ISIN-code: SE0011725084